These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 20722770)
1. Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation. Layton RC; Brasel T; Gigliotti A; Barr E; Storch S; Myers L; Hobbs C; Koster F J Med Primatol; 2011 Feb; 40(1):6-17. PubMed ID: 20722770 [TBL] [Abstract][Full Text] [Related]
2. The African Green Monkey Model of Pneumonic Plague and US Food and Drug Administration Approval of Antimicrobials Under the Animal Rule. Hewitt JA; Lanning LL; Campbell JL Clin Infect Dis; 2020 May; 70(70 Suppl 1):S51-S59. PubMed ID: 32435803 [TBL] [Abstract][Full Text] [Related]
3. Levofloxacin cures experimental pneumonic plague in African green monkeys. Layton RC; Mega W; McDonald JD; Brasel TL; Barr EB; Gigliotti AP; Koster F PLoS Negl Trop Dis; 2011 Feb; 5(2):e959. PubMed ID: 21347450 [TBL] [Abstract][Full Text] [Related]
5. Effect of Delaying Treatment on Efficacy of Ciprofloxacin and Levofloxacin in the African Green Monkey Model of Pneumonic Plague. Campbell JL; Fay MP; Lanning LL; Hewitt JA Clin Infect Dis; 2020 May; 70(70 Suppl 1):S60-S65. PubMed ID: 32435805 [TBL] [Abstract][Full Text] [Related]
6. Cynomolgus macaque model for pneumonic plague. Warren R; Lockman H; Barnewall R; Krile R; Blanco OB; Vasconcelos D; Price J; House RV; Bolanowksi MA; Fellows P Microb Pathog; 2011 Jan; 50(1):12-22. PubMed ID: 21040776 [TBL] [Abstract][Full Text] [Related]
7. Gepotidacin is efficacious in a nonhuman primate model of pneumonic plague. Jakielaszek C; Hossain M; Qian L; Fishman C; Widdowson K; Hilliard JJ; Mannino F; Raychaudhuri A; Carniel E; Demons S; Heine HS; Hershfield J; Russo R; Mega WM; Revelli D; O'Dwyer K Sci Transl Med; 2022 Jun; 14(647):eabg1787. PubMed ID: 35648812 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the rat pneumonic plague model: infection kinetics following aerosolization of Yersinia pestis CO92. Agar SL; Sha J; Foltz SM; Erova TE; Walberg KG; Baze WB; Suarez G; Peterson JW; Chopra AK Microbes Infect; 2009 Feb; 11(2):205-14. PubMed ID: 19073275 [TBL] [Abstract][Full Text] [Related]
9. Delayed diagnosis of fatal pneumonic canine plague: clinical and pathologic features in two naturally infected Colorado dogs. Schaffer PA; Hershkowitz CS; Dowers KL; Golchanour JL; Harris LJ; Aboellial TA; Morley PS; Brault SA; Pabilonia KL; Mason GL; House JA; Daniels JB BMC Vet Res; 2020 May; 16(1):160. PubMed ID: 32450913 [TBL] [Abstract][Full Text] [Related]
10. Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops). Davis KJ; Fritz DL; Pitt ML; Welkos SL; Worsham PL; Friedlander AM Arch Pathol Lab Med; 1996 Feb; 120(2):156-63. PubMed ID: 8712895 [TBL] [Abstract][Full Text] [Related]
11. Clinical and pathologic features of cynomolgus macaques (Macaca fascicularis) infected with aerosolized Yersinia pestis. Van Andel R; Sherwood R; Gennings C; Lyons CR; Hutt J; Gigliotti A; Barr E Comp Med; 2008 Feb; 58(1):68-75. PubMed ID: 19793459 [TBL] [Abstract][Full Text] [Related]
12. Standardized Method for Aerosol Challenge of Rodents with Yersinia pestis for Modeling Primary Pneumonic Plague. Anderson PE; Olson RM; Willix JL; Anderson DM Methods Mol Biol; 2019; 2010():29-39. PubMed ID: 31177429 [TBL] [Abstract][Full Text] [Related]
13. Temporal Progression of Pneumonic Plague in Blood of Nonhuman Primate: A Transcriptomic Analysis. Hammamieh R; Muhie S; Borschel R; Gautam A; Miller SA; Chakraborty N; Jett M PLoS One; 2016; 11(3):e0151788. PubMed ID: 27003632 [TBL] [Abstract][Full Text] [Related]
14. Pneumonic Plague: The Darker Side of Yersinia pestis. Pechous RD; Sivaraman V; Stasulli NM; Goldman WE Trends Microbiol; 2016 Mar; 24(3):190-197. PubMed ID: 26698952 [TBL] [Abstract][Full Text] [Related]
15. Tn-Seq Analysis Identifies Genes Important for Yersinia pestis Adherence during Primary Pneumonic Plague. Eichelberger KR; Sepúlveda VE; Ford J; Selitsky SR; Mieczkowski PA; Parker JS; Goldman WE mSphere; 2020 Aug; 5(4):. PubMed ID: 32759339 [TBL] [Abstract][Full Text] [Related]
16. Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92. Agar SL; Sha J; Foltz SM; Erova TE; Walberg KG; Parham TE; Baze WB; Suarez G; Peterson JW; Chopra AK Microbiology (Reading); 2008 Jul; 154(Pt 7):1939-1948. PubMed ID: 18599822 [TBL] [Abstract][Full Text] [Related]
17. Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of Willix JL; Stockton JL; Olson RM; Anderson PE; Anderson DM Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015027 [TBL] [Abstract][Full Text] [Related]
19. Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague. Welkos S; Pitt ML; Martinez M; Friedlander A; Vogel P; Tammariello R Vaccine; 2002 May; 20(17-18):2206-14. PubMed ID: 12009274 [TBL] [Abstract][Full Text] [Related]
20. Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague. Sha J; Agar SL; Baze WB; Olano JP; Fadl AA; Erova TE; Wang S; Foltz SM; Suarez G; Motin VL; Chauhan S; Klimpel GR; Peterson JW; Chopra AK Infect Immun; 2008 Apr; 76(4):1390-409. PubMed ID: 18227160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]